Avricore Health Inc.
AVCR.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -1.03M | -654.70K | -475.80K | 77.00K | -4.20K |
Total Depreciation and Amortization | 218.60K | 270.00K | 324.10K | 336.80K | 343.80K |
Total Amortization of Deferred Charges | 9.50K | 6.90K | 4.60K | 8.30K | 6.20K |
Total Other Non-Cash Items | 1.08M | 991.00K | 960.90K | 370.40K | 349.40K |
Change in Net Operating Assets | -2.40K | -28.00K | -80.20K | -124.40K | -65.90K |
Cash from Operations | 282.40K | 585.20K | 733.50K | 668.10K | 629.20K |
Capital Expenditure | -101.10K | -123.00K | -133.20K | -381.80K | -531.60K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -19.40K | -22.90K | -17.70K | -25.70K | -25.10K |
Cash from Investing | -120.50K | -145.90K | -150.90K | -407.40K | -556.70K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00 | 0.00 | -30.00K | -30.00K | -30.00K |
Issuance of Common Stock | 70.00K | 71.00K | 86.60K | 69.10K | 16.60K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 51.00K | 51.70K | 41.00K | 28.50K | -10.00K |
Foreign Exchange rate Adjustments | -500.00 | 200.00 | 0.00 | 0.00 | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 212.40K | 491.20K | 623.60K | 289.20K | 62.50K |